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Background
Severe Plasmodium falciparum malaria is a major cause of death in children. The con-
tribution of the parasite burden to the pathogenesis of severe malaria has been 
controversial.
Methods
We documented P. falciparum infection and disease in Tanzanian children followed 
from birth for an average of 2 years and for as long as 4 years.
Results
Of the 882 children in our study, 102 had severe malaria, but only 3 had more than 
two episodes. More than half of first episodes of severe malaria occurred after a 
second infection. Although parasite levels were higher on average when children 
had severe rather than mild disease, most children (67 of 102) had high-density 
infection (>2500 parasites per 200 white cells) with only mild symptoms before 
severe malaria, after severe malaria, or both. The incidence of severe malaria de-
creased considerably after infancy, whereas the incidence of high-density infection 
was similar among all age groups. Infections before and after episodes of severe 
malaria were associated with similar parasite densities. Nonuse of bed nets, placen-
tal malaria at the time of a woman’s second or subsequent delivery, high-transmission 
season, and absence of the sickle cell trait increased severe-malaria risk and parasite 
density during infections.
Conclusions
Resistance to severe malaria was not acquired after one or two mild infections. 
Although the parasite burden was higher on average during episodes of severe ma-
laria, a high parasite burden was often insufficient to cause severe malaria even in 
children who later were susceptible. The diverging rates of severe disease and high-
density infection after infancy, as well as the similar parasite burdens before and 
after severe malaria, indicate that naturally acquired resistance to severe malaria is not 
explained by improved control of parasite density. (Funded by the National Institute 
of Allergy and Infectious Diseases and others.)
The New England Journal of Medicine 
Downloaded from nejm.org at LONDON SCH HYGIENE & TROPICAL MED on February 25, 2020. For personal use only. No other uses without permission. 
 Copyright © 2014 Massachusetts Medical Society. All rights reserved. 
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
n engl j med 370;19 nejm.org may 8, 20141800
A lthough almost 600,000 African children die each year from malaria,1 most infections in children are mild.2,3 
Fundamental questions about the pathogenesis 
of malaria remain unresolved, such as the rela-
tive contributions of parasite burden and host 
inflammation to severe disease.4 In areas where 
transmission is stable, severe malaria is unlikely 
to occur after 5 years of age, presumably as a re-
sult of immunity,5 and mathematical models sug-
gest that protection against noncerebral severe 
malaria develops after one or two infections.6 
The mechanism of protective immunity is un-
clear; it might, for example, involve the reduction 
of parasite density or the blocking of parasite 
virulence to prevent disease. IgG transferred 
from immune adults clears blood-stage parasites 
and symptoms in sick children,7 but the targets 
of protective IgG remain undefined.
To better understand the pathogenesis of se-
vere malaria and acquired immunity, we under-
took an intensive birth-cohort study of 882 chil-
dren in northeastern Tanzania. We examined the 
relationship between the Plasmodium falciparum 
parasite burden and the severity of malaria within 
individual children over time and the risk of se-
vere malaria during the first and subsequent 
infections.
Me thods
Study Population
The study population was part of a longitudinal 
birth cohort in the Muheza district, an area of 
intense malaria transmission with an entomo-
logic inoculation rate of approximately 400 in-
fective mosquito bites annually.8 The incidence 
of malaria declined sharply in this area after the 
study closed in 2006.9 Newborns were enrolled in 
the study between September 2002 and Novem-
ber 2005. Children were followed for an average 
of 2 years and for as long as 4 years. Written in-
formed consent was obtained from all the chil-
dren’s mothers before enrollment.
Study Procedures
Children were examined at birth, once every 2 weeks 
during infancy, once every month after infancy, and 
during any illness. Blood smears were collected at 
all visits, regardless of whether symptoms were 
present. Parasitemia was defined as any P. falci-
parum detected in a Giemsa-stained blood smear, 
and high-density infection requiring parenteral 
treatment was defined as a parasite density of 
more than 2500 parasites per 200 white cells, in 
accordance with Tanzanian Ministry of Health and 
Social Welfare guidelines. P. falciparum–specific 
histidine-rich protein 2 (PfHRP-2) levels in plas-
ma were measured with the use of a sandwich 
enzyme-linked immunosorbent assay (ELISA)10 
(see the Supplementary Appendix, available with 
the full text of this article at NEJM.org).
Children were classified as having severe ma-
laria in accordance with World Health Organiza-
tion (WHO) criteria11 (hemoglobin level <5 g per 
deciliter, prostration, more than one convulsion 
in the past 24 hours, respiratory distress, or hypo-
glycemia). Children were classified as having mod-
erately severe malaria if they did not fulfill the 
WHO criteria but had at least one of the follow-
ing signs: a hemoglobin level lower than 6 g per 
deciliter, hyperthermia (temperature, >40°C), one 
convulsion in the past 24 hours, or a respiratory 
rate greater than 40 breaths per minute. Most 
cases of severe and moderately severe malaria 
(78.4%) were treated with quinine. The results of 
analyses of moderately severe malaria are pre-
sented in the Supplementary Appendix. Children 
were classified as having mild high-density in-
fection if they had a parasite density of more 
than 2500 parasites per 200 white cells in the ab-
sence of severe or moderately severe symptoms. 
Children were followed until the end of the 
study (May 2006) or until they dropped out of 
the study.
The study protocols were approved by the 
Division of Microbiology and Infectious Diseases 
at the U.S. National Institutes of Health and by 
the institutional review boards of Seattle BioMed 
and the Medical Research Coordinating Com-
mittee in Tanzania.
Statistical Analysis
All cases of parasitemia occurring within 28 days 
after a previous case were considered to be a sin-
gle infection. We estimated age-specific inci-
dence rates of infection, mild high-density infec-
tion, and severe malaria using a Nelson–Aalen 
estimator12 with confidence intervals calculated 
by means of a nonparametric bootstrap method. 
A generalized-estimating-equation approach for 
Poisson regression was used to compare age-
specific rates of severe malaria and high-density 
infection. The risk of severe malaria during a 
The New England Journal of Medicine 
Downloaded from nejm.org at LONDON SCH HYGIENE & TROPICAL MED on February 25, 2020. For personal use only. No other uses without permission. 
 Copyright © 2014 Massachusetts Medical Society. All rights reserved. 
Par asite Burden and Severity of Malaria
n engl j med 370;19 nejm.org may 8, 2014 1801
first infection was estimated by dividing the 
number of children with severe malaria during a 
first infection by the total number infected at 
least once; similar risk calculations were per-
formed for subsequent infections, after children 
with previous episodes of severe malaria were 
excluded. Log-transformed parasite density be-
fore and after a first episode of severe malaria 
was compared with the use of a paired t-test.
Cox proportional-hazards models were fit to 
determine the influence of study variables (village 
of residence, use or nonuse of bed nets, presence 
or absence of sickle cell trait, α-thalassemia geno-
type, transmission season [low or high], birth 
season, sex, and a single variable combining 
status with respect to placental malaria and ma-
ternal parity) on time to first episode of severe 
malaria. A multivariate generalized-estimating-
equation model with log-transformed parasite 
density as the dependent variable was developed 
to assess the effect of all study variables on the 
parasite burden. All reported P values are two-
sided; P values lower than 0.05 were considered 
to indicate statistical significance. Details of 
the survival analysis and generalized-estimating-
equation methods are provided in the Supple-
mentary Appendix.
R esult s
Study Population
During the recruitment period, 1045 mothers (of 
1075 children) gave consent to participate and 
gave birth at the Muheza Designated District 
Hospital. After exclusions (see the Supplementa-
ry Appendix), 882 singleton infants were includ-
ed in the analyses (Table 1), of whom 688 (78.0%) 
were followed for at least 1 year. Baseline char-
acteristics were similar in the overall popula-
tion and among the children followed for more 
than 1 year. Most of the children (62.7%) slept 
with bed nets, and among these children, 29.7% 
slept with bed nets that were insecticide-treated. 
The prevalences of sickle cell trait (16.5%) and 
α-thalassemia (11.8% homozygous and 40.9% 
heterozygous) were similar to those in other 
East African populations.13,14
The study encompassed 1762.8 child-years and 
38,261 blood smears, including 6319 P. falciparum–
positive blood smears representing 3933 inde-
pendent infections; 65.4% of the positive blood 
smears were documented during scheduled vis-
its. Of the 882 children, 715 (81.1%) had at least 
one P. falciparum infection. A total of 102 children 
(11.6%) had severe malaria, with 122 episodes of 
severe malaria overall. Most of the children who 
had severe malaria (99 of 102) had only one or 
two episodes. Of the 15 children who had a sec-
ond episode, 7 presented with the same syn-
drome on both occasions, and 7 of 15 second 
episodes occurred during infancy (Fig. S6 in the 
Supplementary Appendix), when the incidence of 
severe malaria peaks. Of the 688 children fol-
lowed for at least 1 year, 624 (90.7%) became 
infected, and 98 (14.2%) had severe malaria.
Table 1. Characteristics of the Study Population.*
Characteristic
Value  
(N = 882)
Maternal age — yr 26.0±6.3
Maternal parity — no. (%)
First delivery 254 (28.8)
Second delivery 201 (22.8)
Third or subsequent delivery 427 (48.4)
Maternal residence area — no. (%)
Magila 144 (16.3)
Muheza township 400 (45.4)
Mkanyageni 188 (21.3)
Bwembwera 150 (17.0)
Bed-net use — no./total no. (%) 455/726 (62.7)
Birth weight — kg 3.2±0.4
Duration of follow-up — wk 104.2±53.5
Sex — no. (%)
Male 457 (51.8)
Female 425 (48.2)
Transmission season at birth — no. (%)
High 432 (49.0)
Low 450 (51.0)
Sickle cell trait — no./total no. (%) 142/861 (16.5)
Parasitemia during follow-up — no. (%) 715 (81.1)
Postneonatal death — no. (%) 35 (4.0)
Parasite-positive blood smears — no./total no. (%) 6319/38,261 (16.5)
Treated at home before presentation — %
Severe malaria 4.1
Mild malaria with high parasite density 2.7
Mild malaria with any parasite density 1.5
* Plus–minus values are means ±SD.
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Thirty-five children (4.0%) died; 11 deaths were 
attributed to malaria. The overall mortality rate 
in our cohort was lower than that previously 
reported in this area15; the difference may be 
related to the intensive follow-up in our study 
(see the Supplementary Appendix). The propor-
tion of childhood deaths attributable to malaria 
(31%) was similar to that in other African com-
munities.16-18
Parasite Burden and Severe Malaria
The ranges of parasite densities during severe 
malaria and during mild or asymptomatic ma-
laria overlapped considerably, both in the overall 
cohort (Fig. S1A in the Supplementary Appendix) 
and in the subset of children who had severe ma-
laria during follow-up (Fig. S1B in the Supple-
mentary Appendix). Assessment of PfHRP-2 levels, 
another measure of parasite biomass, had simi-
lar results (Fig. S1C in the Supplementary Appen-
dix). The mean parasite density was substantially 
higher during episodes of severe malaria than 
during mild or asymptomatic infections (P<0.001), 
largely because severe malaria was rare during 
low-density infections (Fig. S2 in the Supplemen-
tary Appendix). However, most high-density in-
fections were not associated with severe malaria: 
253 of 882 children had a total of 444 high-
density infections with only mild symptoms, 
including 36 completely asymptomatic episodes.
Even among the 102 children who had severe 
malaria, most (67) had high-density infection 
with only mild symptoms before the first episode 
of severe malaria (21 children) (Fig. 1A), after the 
first severe episode (55 children) (Fig. 1B), or both. 
Both parasite density and PfHRP-2 levels were 
significantly higher during a mild high-density 
infection than during an episode of severe ma-
laria; the mean ratio of parasite level during mild 
infection to parasite level during severe episodes 
was 6.3 (95% confidence interval [CI], 3.8 to 10.5; 
P<0.001; 67 children), and the geometric mean 
PfHRP-2 level was 4826 ng per milliliter (95% CI, 
3378 to 6894) during a mild high-density infec-
tion versus 1305 ng per milliliter (95% CI, 516 to 
3298) during a severe episode (P = 0.01; 39 children).
Risk of First Episode of Severe Malaria
The incidence of infection increased during the first 
6 months of life, then remained stable (Fig. 2A). 
The change in timing of the analysis of blood 
smears from every 2 weeks to every month might 
have resulted in an underestimation of the inci-
dence of infection after infancy, but it would not 
have affected the persistent plateau thereafter. 
The overall cumulative incidence rates of infec-
tion, severe malaria, and mild high-density in-
fection were, respectively, 2.41 (95% CI, 2.21 to 
2.62), 0.05 (95% CI, 0.04 to 0.06), and 0.26 (95% 
CI, 0.22 to 0.30) episodes per child-year. The in-
cidence of severe malaria — but not the incidence 
of mild high-density infection — diminished af-
ter infancy (Fig. 2B). The incidence rates of infec-
tion and severe malaria are similar to those that 
have been reported in other areas of high trans-
mission19,20 (see the Supplementary Appendix).
The median age at the first episode of severe 
malaria was 38.7 weeks (interquartile range, 
28.6 to 63.8). The risk of severe malaria did not 
decrease after the first infection; approximately 
50% of children had at least two mild or asymp-
tomatic infections before their first severe epi-
sode (Fig. 2C).
Severe Malarial Anemia
As in other African communities,21,22 most chil-
dren with severe malaria typically presented with 
a single condition (Fig. 3), such as respiratory dis-
tress, convulsions, or severe anemia. Children had 
more than one condition in only 12.3% of severe 
episodes (15 of 122), which is similar to the pro-
portions reported in previous studies.21,22 Chil-
dren with convulsions were older and had lower 
parasite densities than children with severe ane-
mia, although the differences were not signifi-
cant (P = 0.09 and P = 0.21, respectively) (Table S1 
in the Supplementary Appendix). Of the 102 chil-
dren who had severe illness, 6 (5.9%) died during 
an episode of severe malaria. Three of the 15 chil-
dren (20%) who presented with overlapping se-
vere malaria conditions died.
Most children with severe malarial anemia 
(26 of 40, 65%) had their hemoglobin level mea-
sured in the previous 2 months. These children 
had a median reduction of 47% (interquartile 
range, 28 to 65) in the hemoglobin level at the 
time of severe malarial anemia. In 15 of the 
26 children (58%), hemoglobin levels were high-
er than 8 g per deciliter in the 2 months before 
the episode of severe malarial anemia, which 
suggests that there was a decrease of more 
than 3 g per deciliter during the acute infec-
tion. Fewer children (8 of 26, 31%) had a hemo-
globin level lower than 7 g per deciliter in the 
2 months before an episode of severe malarial 
anemia.
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Placental Malaria and Other Risk Factors
In Cox regression analyses of the time to the first 
episode of severe malaria, placental malaria and 
maternal parity were combined as one variable, 
because these factors interact to influence the in-
cidence of infection.23 Bed-net use (P<0.001) and 
residence in Muheza or Mkanyageni (P<0.001 
and P = 0.02, respectively) reduced the risk of se-
vere malaria, whereas the high-transmission sea-
son (P = 0.05) and placental malaria at the time 
of second or subsequent delivery (P = 0.04) in-
creased the risk. In a multivariate Cox model 
(Table 2), bed-net use and residency in Muheza or 
Mkanyageni reduced the risk of severe malaria by 
52%, 61%, and 53%, respectively (P = 0.001, 
P<0.001, and P = 0.02, respectively); sickle cell 
trait reduced the risk by 41% (P = 0.11), a finding 
that was similar to the results of previous stud-
ies.24 The high-transmission season increased the 
risk of severe malaria (P = 0.05).
We fit a generalized-estimating-equation model 
with log-transformed parasite density as the depen-
dent variable (Table 2). Sickle cell trait and bed-net 
use significantly reduced parasite density (P<0.001), 
whereas placental malaria at the time of second 
or subsequent delivery (P = 0.04) and the high-
transmission season (P<0.001) significantly in-
creased parasite density. The effects of these 
factors on parasite density parallel their effects 
on the risk of severe malaria, which suggests 
Figure 1. Risk of Severe Malaria and Parasite Density.
Panel A shows high-density infections with only mild 
symptoms (blue circles) that occurred before severe 
malaria episodes (red circles) in 21 of 102 children, 
shown according to parasite density and age. Parasite 
levels during mild high-density infections that occurred 
before an episode of severe malaria were higher on 
 average than parasite levels during episodes of severe 
malaria (mean ratio, 8.0; 95% confidence interval [CI], 
3.0 to 21.2). The median time from the episode of 
high-density infection to the first episode of severe 
malaria was 154 days (interquartile range, 105 to 222). 
Panel B shows high-density infections with only mild 
symptoms that occurred after severe malaria episodes 
in 55 of 102 children, shown according to parasite den-
sity and age. Parasite levels during mild high-density 
infections after severe malaria were higher than para-
site levels during episodes of severe malaria (mean ratio, 
5.0; 95% CI, 2.9 to 8.6). Panel C shows the mean para-
site density of infections in the 9 months before, during, 
and in the 9 months after a child’s first severe malaria 
episode. Only children who had at least one episode of 
parasitemia during the 9 months before and at least one 
episode of parasitemia during the 9 months after their 
first episode of severe malaria are included (58 children). 
The bar within each box indicates the median parasite 
density, the lower and upper ends of the box indicate 
the interquartile range, the bars below and above the 
boxes indicate 5th and 95th percentiles, and the circles 
indicate outliers.
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that interventions that reduce parasite density 
might prevent life-threatening disease by a 
mechanism that differs from naturally acquired 
resistance.
Immunity to Severe Malaria after Infancy
Rates of high-density infection and severe ma-
laria (Table S3 in the Supplementary Appendix) 
did not differ significantly during the first 24 weeks 
of life (rate ratio, 1.61; P = 0.07), but rates of high-
density infection significantly exceeded rates of 
severe malaria thereafter (rate ratios of 2.26, 5.58, 
and 13.58 for children 24 to 48, >48 to 96, and 
>96 weeks of age, respectively; P<0.001 for all 
comparisons) (Fig. 2B). Changes in the rates of 
high-density infection and severe malaria also 
diverged with age (Table S4 in the Supplementary 
Appendix): in comparison with peak incidence 
among children older than 24 weeks through 
48 weeks of age, rate ratios for severe malaria 
were estimated as 0.46 (P<0.001) for children 
older than 48 weeks through 96 weeks of age and 
0.16 (P<0.001) for children older than 96 weeks 
of age, which is consistent with acquired immu-
nity. In contrast, the rate of high-density infec-
tion remained stable after 24 weeks of age.
Parasite densities in individual children did not 
differ significantly between infections that oc-
curred in the 9 months before and those that 
oc curred in the 9 months after the first episode 
of severe malaria (58 children, P = 0.56) (Fig. 1C); 
infections during the first 4 months of life were 
excluded from this analysis, because parasite 
levels at this age are lower (Fig. S5 in the Supple-
mentary Appendix). Assessment of PfHRP-2 levels 
had similar results (34 children; geometric mean 
level, 496 ng per milliliter [95% CI, 245 to 1006] 
before vs. 717 ng per milliliter [95% CI, 348 to 
1477] after severe malaria; P = 0.30). Similar results 
were also obtained with the use of a 3-month 
window rather than a 9-month window.
Figure 2. Risk of Severe Malaria, Infection, and High-
Density Infection.
Panel A shows the cumulative age-specific incidence 
rate of infections. Panel B shows the cumulative age-
specific incidence rate of severe malaria and of high-
density infection with no more than mild symptoms. 
I bars in both panels indicate 95% confidence intervals. 
Panel C shows the risk of severe malaria during sequential 
infections. In the fractions above each bar, the numerator 
is the number of children with severe malaria at that par-
ticular infection, and the denominator is the total number 
of children who had the indicated number of infections. 
For example, only 25 children had at least 14 infections, 
and 1 of those children had a first severe malaria episode 
at the time of that 14th infection.
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Discussion
Most of the children in our study had severe ma-
laria after one or more previous infections, rather 
than during their first infection, and most such 
children had much higher parasite densities (six 
times as high) with only mild symptoms in previ-
ous or subsequent infections. Taken together, the 
data suggest that severe malaria cannot be ex-
plained by parasite burden alone and that factors 
such as parasite virulence and host inflammation 
might play key roles in immunopathogenesis. 
Furthermore, acquired immunity to severe ma-
laria is not explained by improved control of 
parasite density and therefore might target dis-
tinct antigens or processes involved in severe 
syndromes.
On the basis of rates of infection and hospi-
talization due to malaria, the risk of noncerebral 
severe malaria was thought to be limited to the 
first infection or two.6 This prospective study 
provides evidence that the risk of severe malaria 
is stable over several infections.25 As transmission 
decreases in many parts of Africa, the risk of se-
vere malaria shifts to older age groups,26 and the 
idea that only minimal exposure is required to 
generate immunity may lead to complacency re-
garding this danger. Conversely, the relatively 
poor efficacy of the antimalarial agents recom-
mended at the time of our study (treatment with 
artemisinins was implemented as policy after our 
study ended) may have contributed to high trans-
mission, as well as to the early peak incidence and 
rapid acquisition of immunity to severe malaria.
The low risk of recurrent severe malaria and 
the rapid decrease in the incidence of severe 
malaria after infancy are consistent with earlier 
evidence that immunity to severe malaria is ac-
quired rapidly.6 Recurrences of severe malaria 
are equally likely to be the same syndrome as 
the first episode or a different syndrome (Table 
S6 in the Supplementary Appendix). This fact 
and the observation that a child’s single episode 
of severe malaria is manifested as a single defin-
ing syndrome suggest that immunity to severe 
malaria is not syndrome-specific and therefore 
that targets of protective immunity may be con-
served among syndromes.
Our data suggest that the total parasite burden 
contributes to the pathogenesis of severe ma-
laria, although this association does not prove 
causality: parasite levels are higher during severe 
episodes, and several risk factors for severe ma-
laria also affect parasite density. Because these 
factors might modify the risk of severe malaria 
through their effect on parasite density, inter-
ventions designed to reduce parasite density, such 
as vaccines targeting merozoites, might provide 
at least partial protection against severe disease. 
Possibly because responses to multiple variants 
are required to block erythrocyte infection,27,28
early merozoite vaccine candidates did not reduce 
levels of blood-stage parasites,29-31 and their ef-
ficacy against severe malaria has therefore not 
been assessed.
Our findings are in agreement with those of 
earlier studies showing that sickle cell trait,24,32
the low-transmission season,33 and bed-net 
use34,35 are associated with reduced parasite 
density. A new finding is that placental malaria 
at the time of second or subsequent delivery in-
creases the risk of severe malaria in a woman’s 
offspring, which is similar to the reported ef-
fect of placental malaria in such women on the 
overall risk of infection23 and on the risk of 
Severe AnemiaRespiratory
Distress
Prostration
Hypoglycemia
Convulsions
31
31
32
12
1
1
1
1
1
2
2
3
3
1
Figure 3. Discrete and Overlapping Syndromes among Children with Severe 
Malaria.
Severe anemia was defined as a hemoglobin level lower than 5 g per deciliter. 
Numbers denote the number of children with each condition.
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clinical malaria36 in their offspring. The mecha-
nism behind this observation is unknown, but it 
suggests that in utero exposure might influence 
immune responses to malaria parasites in early 
childhood.
Despite its association with disease, parasite 
burden alone does not completely explain severe 
malaria. Most children had high-density infec-
tion with only mild symptoms before the epi-
sode of severe malaria (21 of 102 children), after 
the episode (55 of 102), or both, and most chil-
dren (67 of 102), regardless of whether they ever 
had a high-density infection, did not have their 
severe malaria episode at the time of their 
highest-density infection. Parasite sequestration 
complicates the quantification of parasite density 
in blood smears; however, analysis of PfHRP-2 
levels, which are believed to be a better measure 
of total parasite mass, yielded the same conclu-
sions as our blood-smear data.
We found that naturally acquired resistance 
to severe malaria was not accompanied by im-
proved control of parasite density. Although the 
incidence of severe malaria decreases signifi-
cantly after the first year of life, children continue 
to have high-density infections. Mean parasite 
densities do not differ significantly during infec-
tions occurring before and those occurring after 
severe malaria episodes. An understanding of 
parasite and host factors other than parasite 
burden that are associated with severe malaria 
might lead to identification of targets for new 
vaccines. For example, P. falciparum erythrocyte 
membrane protein 1 (PfEMP1), a family of highly 
variant proteins found on the surface of infected 
erythrocytes, has been linked to severe disease37,38 
and might be targeted by vaccines.
We observed that severe malarial anemia was 
usually caused by an abrupt decrease in the he-
moglobin concentration, often exceeding 3 g per 
Table 2. Factors That Influenced the Risk of Severe Malaria and Parasite Density during Infection.
Factor Severe Malaria* Parasite Density†
Hazard Ratio 
(95% CI) P Value
Coefficient 
(95% CI) P Value
Sickle cell genotype hemoglobin AS vs. AA 0.59 
(0.30 to 1.14)
0.11 −0.46 
(−0.68 to −0.23)
<0.001
Bed-net use vs. no bed-net use 0.48 
(0.32 to 0.73)
0.001 −0.52 
(−0.71 to −0.33)
<0.001
Male sex 0.72 
(0.48 to 1.06)
0.10 0.03 
(−0.14 to –0.20)
0.70
Village of residence
Magila Reference — Reference —
Bwembwera 0.87 
(0.50 to 1.52)
0.63 0.16 
(−0.08 to 0.40)
0.20
Mkanyageni 0.47 
(0.25 to 0.87)
0.02 0.25 
(0.02 to 0.48)
0.04
Muheza township 0.39 
(0.23 to 0.66)
<0.001 −0.10 
(−0.34 to 0.14)
0.42
High-transmission season vs. low-transmission 
season
1.49 
(1.00 to 2.22)
0.05 0.31 
(0.19 to 0.43)
<0.001
Maternal parity and placental malaria status
First delivery, no placental malaria Reference — Reference —
Second or subsequent delivery, no placental 
malaria
1.11 
(0.66 to 1.86)
0.70 0.02 
(−0.19 to 0.24)
0.84
First delivery, placental malaria 1.12 
(0.44 to 2.82)
0.81 0.16 
(−0.20 to 0.52)
0.38
Second or subsequent delivery, placental malaria 1.86 
(0.92 to 3.77)
0.08 0.30 
(0.01 to 0.59)
0.04
* A Cox multivariate model was used to assess the time to the first episode of severe malaria.
† A multivariate generalized-estimating-equation model was used to assess parasite density (log10 number of parasites 
per 200 white cells) during infection.
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deciliter. Severe malarial anemia in children is 
commonly believed to develop as a chronic pro-
cess, but the pattern we observed indicated a 
substantial contribution of the acute infection to 
hemoglobin loss.39,40 These two distinct dynam-
ics of hemoglobin decrease could represent dif-
ferent pathologic processes.39
Our study provides direct evidence that severe 
malaria is unlikely to recur but that it com-
monly occurs after previous infections, including 
high-density infections. The immunity to severe 
malaria is not related to improved control of 
parasite density. The epidemiologic evidence sug-
gests that naturally acquired immunity targets a 
conserved feature of the various severe-malaria 
syndromes, such as parasite virulence or host in-
flammation. An understanding of the natural 
history of P. falciparum infection and disease can 
guide mechanistic studies of the pathogenesis of 
and immunity to severe malaria, which in turn 
can lead to the development of new therapeutics.
Supported by the Intramural Research Program of the National 
Institute of Allergy and Infectious Diseases (NIAID), National In-
stitutes of Health (NIH), and by grants from the NIAID extra-
mural program (R01AI52059), the Fogarty International Center 
(D43 TW005509) of the NIH, and the Foundation for the NIH 
through the Grand Challenges in Global Health Initiative, which 
is funded by the Bill and Melinda Gates Foundation (1364).
Disclosure forms provided by the authors are available with 
the full text of this article at NEJM.org.
We thank the mothers and their children in the Muheza Dis-
trict for participating in the study; Theonest Mutabingwa for 
leading the clinical team that managed the care and data collection 
for study participants; Kun-Lin Lee for performing the PfHRP-2 
assays; Wonjong Moon, Bess Sorensen, and Melissa Bolla for 
database management; Dr. Michael Fay for advice on statistical 
analyses; and Prof. Alassane Dicko for commenting on an earlier 
version of the manuscript.
References
1. World malaria report. Geneva: World 
Health Organization, 2012.
2. Greenwood BM, Bradley AK, Green-
wood AM, et al. Mortality and morbidity 
from malaria among children in a rural 
area of The Gambia, West Africa. Trans R 
Soc Trop Med Hyg 1987;81:478-86.
3. Greenwood B, Marsh K, Snow R. Why 
do some African children develop severe 
malaria? Parasitol Today 1991;7:277-81.
4. Mackintosh CL, Beeson JG, Marsh K. 
Clinical features and pathogenesis of se-
vere malaria. Trends Parasitol 2004;20: 
597-603.
5. Doolan DL, Dobaño C, Baird JK. Ac-
quired immunity to malaria. Clin Micro-
biol Rev 2009;22:13-36.
6. Gupta S, Snow RW, Donnelly CA, 
Marsh K, Newbold C. Immunity to non-
cerebral severe malaria is acquired after 
one or two infections. Nat Med 1999;5: 
340-3.
7. McGregor IA. The passive transfer of 
human malarial immunity. Am J Trop 
Med Hyg 1964;3:Suppl:237-9.
8. Ellman R, Maxwell C, Finch R, Shayo 
D. Malaria and anaemia at different alti-
tudes in the Muheza district of Tanzania: 
childhood morbidity in relation to level of 
exposure to infection. Ann Trop Med 
Parasitol 1998;92:741-53.
9. Mtove G, Amos B, Nadjm B, et al. De-
creasing incidence of severe malaria and 
community-acquired bacteraemia among 
hospitalized children in Muheza, north-
eastern Tanzania, 2006-2010. Malar J 2011; 
10:320.
10. Noedl H, Bronnert J, Yingyuen K, 
Attl mayr B, Kollaritsch H, Fukuda M. 
Simple histidine-rich protein 2 double-site 
sandwich enzyme-linked immunosorbent 
assay for use in malaria drug sensitivity 
testing. Antimicrob Agents Chemother 
2005;49:3575-7.
11. Severe falciparum malaria: World 
Health Organization, Communicable Dis-
eases Cluster. Trans R Soc Trop Med Hyg 
2000;94:Suppl 1:S1-S90.
12. Nelson W. Graphical analysis of sys-
tem repair data. J Qual Technol 1988;20: 
24-35.
13. Piel FB, Patil AP, Howes RE, et al. 
Global distribution of the sickle cell gene 
and geographical confirmation of the 
malaria hypothesis. Nat Commun 2010; 
1:104.
14. Wambua S, Mwangi TW, Kortok M, 
et al. The effect of alpha+-thalassaemia on 
the incidence of malaria and other dis-
eases in children living on the coast of 
Kenya. PLoS Med 2006;3(5):e158.
15. Salum FM, Wilkes TJ, Kivumbi K, 
Curtis CF. Mortality of under-fives in a 
rural area of holoendemic malaria trans-
mission. Acta Trop 1994;58:29-34.
16. Snow RW, Korenromp EL, Gouws E. 
Pediatric mortality in Africa: Plasmodium 
falciparum malaria as a cause or risk? Am J 
Trop Med Hyg 2004;71:Suppl:16-24.
17. Rowe AK, Rowe SY, Snow RW, et al. 
The burden of malaria mortality among 
African children in the year 2000. Int J 
Epidemiol 2006;35:691-704.
18. Nevill CG, Some ES, Mung’ala VO, et al. 
Insecticide-treated bednets reduce mortality 
and severe morbidity from malaria among 
children on the Kenyan coast. Trop Med Int 
Health 1996;1:139-46.
19. Snow RW, Schellenberg JR, Peshu N, 
et al. Periodicity and space-time cluster-
ing of severe childhood malaria on the 
coast of Kenya. Trans R Soc Trop Med Hyg 
1993;87:386-90.
20. Snow RW, Omumbo JA, Lowe B, et al. 
Relation between severe malaria morbid-
ity in children and level of Plasmodium 
falciparum transmission in Africa. Lancet 
1997;349:1650-4.
21. Marsh K, Forster D, Waruiru C, et al. 
Indicators of life-threatening malaria in 
African children. N Engl J Med 1995;332: 
1399-404.
22. Reyburn H, Mbatia R, Drakeley C, et 
al. Association of transmission intensity 
and age with clinical manifestations and 
case fatality of severe Plasmodium falci-
parum malaria. JAMA 2005;293:1461-70.
23. Mutabingwa TK, Bolla MC, Li JL, et al. 
Maternal malaria and gravidity interact to 
modify infant susceptibility to malaria. 
PLoS Med 2005;2(12):e407.
24. Aidoo M, Terlouw DJ, Kolczak MS, 
et al. Protective effects of the sickle cell 
gene against malaria morbidity and mor-
tality. Lancet 2002;359:1311-2.
25. Erunkulu OA, Hill AV, Kwiatkowski 
DP, et al. Severe malaria in Gambian chil-
dren is not due to lack of previous expo-
sure to malaria. Clin Exp Immunol 1992; 
89:296-300.
26. O’Meara WP, Bejon P, Mwangi TW, et 
al. Effect of a fall in malaria transmission 
on morbidity and mortality in Kilifi, Kenya. 
Lancet 2008;372:1555-62.
27. Richards JS, Beeson JG. The future for 
blood-stage vaccines against malaria. Im-
munol Cell Biol 2009;87:377-90.
28. Thera MA, Doumbo OK, Coulibaly D, 
et al. A field trial to assess a blood-stage 
malaria vaccine. N Engl J Med 2011;365: 
1004-13.
29. Ogutu BR, Apollo OJ, McKinney D, 
et al. Blood stage malaria vaccine eliciting 
high antigen-specific antibody concentra-
tions confers no protection to young chil-
dren in Western Kenya. PLoS One 2009; 
4(3):e4708.
30. Malkin E, Long CA, Stowers AW, et al. 
Phase 1 study of two merozoite surface 
protein 1 (MSP1(42)) vaccines for Plasmo-
dium falciparum malaria. PLoS Clin Trials 
2007;2(4):e12.
31. Sagara I, Dicko A, Ellis RD, et al. A ran-
domized controlled phase 2 trial of the 
blood stage AMA1-C1/Alhydrogel malaria 
The New England Journal of Medicine 
Downloaded from nejm.org at LONDON SCH HYGIENE & TROPICAL MED on February 25, 2020. For personal use only. No other uses without permission. 
 Copyright © 2014 Massachusetts Medical Society. All rights reserved. 
n engl j med 370;19 nejm.org may 8, 20141808
Par asite Burden and Severity of Malaria
vaccine in children in Mali. Vaccine 2009; 
27:3090-8.
32. Williams TN, Mwangi TW, Wambua 
S, et al. Sickle cell trait and the risk of 
Plasmodium falciparum malaria and other 
childhood diseases. J Infect Dis 2005;192: 
178-86.
33. Molineaux L, Gramiccia G. The Garki 
project: research on the epidemiology and 
control of malaria in the Sudan savanna 
of West Africa. Geneva: World Health Or-
ganization, 1980.
34. Procacci PG, Lamizana L, Kumlien S, 
Habluetzel A, Rotigliano G. Permethrin-
impregnated curtains in malaria control. 
Trans R Soc Trop Med Hyg 1991;85:181-5.
35. Snow RW, Rowan KM, Lindsay SW, 
Greenwood BM. A trial of bed nets (mos-
quito nets) as a malaria control strategy 
in a rural area of The Gambia, West Africa. 
Trans R Soc Trop Med Hyg 1988;82:212-5.
36. Schwarz NG, Adegnika AA, Breitling 
LP, et al. Placental malaria increases ma-
laria risk in the first 30 months of life. 
Clin Infect Dis 2008;47:1017-25.
37. Warimwe GM, Fegan G, Musyoki JN, et 
al. Prognostic indicators of life-threatening 
malaria are associated with distinct para-
site variant antigen profiles. Sci Transl 
Med;4:129ra45.
38. Warimwe GM, Keane TM, Fegan G, 
et al. Plasmodium falciparum var gene 
expression is modified by host immu-
nity. Proc Natl Acad Sci U S A 2009;106: 
21801-6.
39. Weatherall DJ, Abdalla S. The anae-
mia of Plasmodium falciparum malaria. 
Br Med Bull 1982;38:147-51.
40. Casals-Pascual C, Roberts DJ. Severe 
malarial anaemia. Curr Mol Med 2006;6: 
155-68.
Copyright © 2014 Massachusetts Medical Society.
 
The New England Journal of Medicine 
Downloaded from nejm.org at LONDON SCH HYGIENE & TROPICAL MED on February 25, 2020. For personal use only. No other uses without permission. 
 Copyright © 2014 Massachusetts Medical Society. All rights reserved. 
